Atrius Health Central OB/GYN CME Presents: OB/GYN February 2025 CME/CNE, 2/5/2025

February 5, 2025

Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN meeting on February 5,2025. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.

Educational Needs Addressed
In this meeting, Atrius Health discussed the current challenges, guideline advancements and treatment in OB/GYN practice as identified by their internal specialists and CME planning committee. The latest practice data and findings were discussed with the goal of further improving internal practice and treatments.

Target Audience

Atrius Health OB/GYN Clinicians

Learning Objectives

At the completion of this activity, participants will be better able to:

  • Dyspareunia: Expand differential diagnoses for dyspareunia, explore the workup and management with a systems-based approach, review efficacy of treatments
  • KIND program: Review scope of disabled population within Atrius OBGYN, review unique logistical scenarios and discuss resources available to patients and providers
  • Pessary Overview: Review evidence-based approach to selection/fitting/maintenance of different pessary types, discuss risks and long-term outcomes of pessary use for different indications
  • Announcements: Review OBGYN-related practice and personnel updates, CME resources
  • Pessary Infection Control: Review updated infection control guidelines to be applied across the OBGYN service line to maintain consistent best-practice approach
  • Specialty Update: Leadership update
  • Weight Bias: Review conscious and unconscious biases direct at obese patients, discuss risks and outcomes for obese patients, review resources available for patients and providers related to the prevention/management/treatment of obesity
  • ACOG updates: Provide updates to ACOG-endorses clinical guidelines
Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 3.00 MA Risk Management
  • 3.00 ANCC
    • 1.00 ANCC Pharmacology
  • 3.00 Participation
Course opens: 
02/05/2025
Course expires: 
03/05/2025
Event starts: 
02/05/2025 - 8:00am EST
Event ends: 
02/05/2025 - 11:30am EST
Add to calendar: 
Rating: 
0

Faculty Presenters and Disclosures
Christopher Morrison, MD
Course Director
Obstetrics and Gynecology
Atrius Health

Janet Li, MD
Planning Commitee and Speaker
Urogynecology
Atrius Health

Drs. Hale, Li,  Morrison, Rice, Sonia Rivera Saenz and Kathleen Nolan, NP have no relevant financial relationships to disclose. Mallika Anand MD is co-founder and shareholder of Levaira, Inc.

The faculty do not plan on discussing unlabeled/investigational uses of a commercial product.

Planning Committee
Drs. Li, Mayhew, Morrison, Platek and Richardson have no relevant financial relationships to disclose. Meaghan Bride, NP is a trainer for Organon/Merck & Co.

Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships: Michael Burk, BS, Operations Manager; Daniel Alford, MD, Assistant Dean.

Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

 

 

 

In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Atrius Health. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

 

Physician AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management
This program includes 3 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Nursing Accreditation
Contact Hours: 3, of which 1.0 are eligible for pharmacology credit.

Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 3 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Available Credit

  • 3.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 3.00 MA Risk Management
  • 3.00 ANCC
    • 1.00 ANCC Pharmacology
  • 3.00 Participation
Please login or register to take this course.